Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Radiodermatitis 2Head and Neck Neoplasms 1Alopecia 1

Interventions

pembrolizumab 304Paclitaxel 206Carboplatin 200Gemcitabine 173Cisplatin 139Docetaxel 138Cyclophosphamide 136Nivolumab 129Bevacizumab 118Injections 111fludarabine 96atezolizumab 91Pemetrexed 90Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 71Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Lenalidomide 55Ipilimumab 55Midazolam 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Norepinephrine × Clear all
NCT01263366 2013-04-19

Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients

ProCertus BioPharm, Inc

Phase 1 Terminated
10 enrolled

Radiodermatitis

NCT01367990 2012-03-23

Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy

ProCertus BioPharm, Inc

Phase 1 Terminated
3 enrolled
Head & Neck

Alopecia, Head and Neck Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡